betamethasone / sulfacetamide
- RxCUI
- 1008900
- RxNorm name
- betamethasone / sulfacetamide
- Term type
- MIN
- Status
- Active
- Updated
- 2026-06-13 07:07:05
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | D10AF | Antiinfectives for treatment of acne | ATC1-4 | | sulfacetamide |
| ATC | S03BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S02BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | C05AA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | R01AD | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | | betamethasone |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | | betamethasone |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | | betamethasone |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | | betamethasone |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | | betamethasone |
| ATC | H02AB | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | R03BA | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | S01AB | Sulfonamides | ATC1-4 | | sulfacetamide |
| FDASPL | D013449 | Sulfonamides | CHEM | has_chemical_structure | sulfacetamide |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000175503 | Sulfonamide Antibacterial | EPC | has_epc | sulfacetamide |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D013409 | Sulfacetamide | CHEM | has_ingredient | sulfacetamide |
| MEDRT | D003320 | Corneal Ulcer | DISEASE | may_treat | sulfacetamide |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | sulfacetamide |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sulfacetamide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D004427 | Ear Diseases | DISEASE | may_treat | sulfacetamide |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | sulfacetamide |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | sulfacetamide |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | sulfacetamide |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000009946 | Para-Aminobenzoic Acid Inhibitors | MOA | has_moa | sulfacetamide |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000008344 | Cellular Growth Phase Arrest | PE | has_pe | sulfacetamide |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | sulfacetamide |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000009935 | Decreased Folic Acid Modification | PE | has_pe | sulfacetamide |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | TTY | MIN |
| CODES | RxCUI | 1008900 |
| NAMES | RXNAV_STR | betamethasone / sulfacetamide |
| NAMES | RxNorm Name | betamethasone / sulfacetamide |